0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Carglumic Acid Market, Growth, Competitive Landscape, Regional Outlook And Covid-19 Impact Analysis by Fact MRThe global market for carglumic acid is expected to increase from US$ 152.5 million in 2023 to US$ 314.4 million in 2033, according to Fact.MR. This represents a CAGR between 2023 and 2033 of more than 7.5%. The creation of novel treatments and ongoing innovation are what define the global pharmaceutical and healthcare sectors. Carglumic Acid, a drug used to treat a rare metabolic condition...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Carglumic Acid Market, Revenue Analysis & Region And Country Forecast by Fact MRFact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR, a company that offers market research and competitive intelligence, the demand for carglumic acid in the global market is expected to reach US$ 152.5 million in 2023 and increase at a CAGR of 7.5% from 2023 to 2033. The use of carglumic acid in the treatment of urea...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Do Price Fluctuations Affect the Carglumic Acid Market?Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033. Carglumic acid, a synthetic structural analog of N-acetylglutamate (NAG), is primarily used to treat hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. This rare genetic disorder leads to an accumulation...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Does Carglumic Acid Compare to Alternative Treatments?Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033. Carglumic acid, a synthetic structural analog of N-acetylglutamate (NAG), is primarily used to treat hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency. This rare genetic disorder leads to an accumulation...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Спонсоры
google-site-verification: google037b30823fc02426.html
Спонсоры